🔎 Trials Near Me

Akèy › Ensifizans renn › Texas

Etid klinik pou Ensifizans renn nan Texas

15 etid pou Ensifizans renn ap chèche patisipan nan sit nan Texas.

Vil nan Texas

Tèks ofisyèl etid la (Anglè)

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • Cussimanio Research Group LLC, Austin
  • Research Management, Inc., Austin
  • MW Clinical Research Center, Beaumont
  • ak 22 plis
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma

  • University of Texas - MD Anderson Cancer Center, Houston
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT05287945

Pivotal Study of the Velocity™ pAVF System

  • Advanced Dallas Hospital, Dallas
  • Aqua Research, Houston
  • Humble Vascular Surgical Center, Humble
  • ak 2 plis
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07153939

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

  • Research Site, Beaumont
  • Research Site, Dallas
  • Research Site, Houston
  • ak 1 plis
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Aug 14, 2026 · NCT06749457

Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System

  • University of Texas Southwestern Medical Center, Dallas
  • Houston Methodist, Houston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 10, 2026 · NCT04634916

Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 20, 2026 · NCT04163614

Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula

  • Houston Methodist Hospital, Houston
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jul 14, 2026 · NCT06516653

Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants

  • aQua Research Institute, LLC, Houston
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Jul 6, 2026 · NCT06613568

Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)

  • Flow Vascular, Houston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 23, 2026 · NCT07211035

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

  • Baylor Scott & White Heart and Vascular Hospital - Dallas, Dallas
  • Houston Methodist Hospital, Houston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 1, 2026 · NCT06422871

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

  • Baylor Scott & White Heart and Vascular Hospital, Dallas
  • Aqua Research Institute Llc, Houston
Ap rekrite
Laj 18 a 84 · Tout sèks · Mizajou Apr 13, 2026 · NCT06190717

Shingrix in Renal Transplant Recipients

  • Baylor College of Medicine, Houston
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Apr 8, 2026 · NCT04128189

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • University of Texas Southwestern, Dallas
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Mar 24, 2026 · NCT06217302

SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

  • Saint David's HealthCare Partnership, L.P., LLP, Austin
  • A&V Doctors PLLC, El Paso
  • Houston Methodist Research Institute, Houston
  • ak 2 plis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 17, 2026 · NCT06001827

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

  • Baylor Heart and Vascular, Dallas
  • Houston Methodist Hopsital, Houston
Ap rekrite
Laj 18 a 90 · Tout sèks · Mizajou Dec 22, 2025 · NCT04671771

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.